3 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
Follow Peripheral T-cell Lymphoma: new trials by email Literature Review of Peripheral T-cell Lymphoma trials Research Report on Peripheral T-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study BEAC, Cladribine combined with BEAC - Peripheral T-cell Lymphoma | Phase 3 | Unknown | Ruijin Hospital | 266 | 2020-10-17 | 2021-05-11 |
| Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma Cyclophosphamide, pegylated liposomal doxorubicin, Vincristine - Peripheral T-cell Lymphoma | Phase 3 | Unknown | Peking University | 244 | 2019-05-10 | 2019-05-16 |
| Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma Decitabine, Cyclophosphamide, Doxorubicin - Peripheral T-cell Lymphoma | Phase 3 | Unknown | Southwest Hospital, China | 100 | 2018-06-01 | 2018-06-12 |
Lymphoma, T-Cell, Peripheral (3)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Lymphoma, T-Cell (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3)
Cyclophosphamide (2) · Doxorubicin (2) · Prednisone (2) · Vincristine (2) · 1-dodecylpyridoxal (1) · BAEC protocol (1) · Decitabine (1) · liposomal doxorubicin (1)
Peking University (1) · Ruijin Hospital (1) · Southwest Hospital, China (1)
China (2)
Jieping Chen, MD,PhD (1) · Jun Zhu, PHD (1) · Weili Zhao (1) · Xi Li, MD (1)